PA
IART icon

Parallel Advisors’s Integra LifeSciences IART Stock Holding History

Parallel Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.6K Buy
2,147
+1,281
+148% +$17.9K ﹤0.01% 2302
2026
Q1 		$8.16K Buy
866
+266
+44% +$2.92K ﹤0.01% 2841
2025
Q4 		$7.45K Sell
600
-505
-46% -$6.71K ﹤0.01% 2715
2025
Q3 		$15.8K Buy
1,105
+405
+58% +$5.55K ﹤0.01% 2366
2025
Q2 		$8.59K Buy
700
+283
+68% +$4.11K ﹤0.01% 2538
2025
Q1 		$9.17K Hold
417
– – ﹤0.01% 2469
2024
Q4 		$9.46K Buy
417
+363
+672% +$7.92K ﹤0.01% 2427
2024
Q3 		$981 Sell
54
-281
-84% -$6.51K ﹤0.01% 3041
2024
Q2 		$9.76K Buy
335
+166
+98% +$4.92K ﹤0.01% 2329
2024
Q1 		$5.99K Sell
169
-363
-68% -$14.5K ﹤0.01% 2476
2023
Q4 		$23.2K Buy
532
+177
+50% +$6.97K ﹤0.01% 1842
2023
Q3 		$13.6K Sell
355
-36
-9% -$1.51K ﹤0.01% 2055
2023
Q2 		$16.1K Sell
391
-316
-45% -$15.2K ﹤0.01% 1950
2023
Q1 		$40.6K Buy
707
+259
+58% +$14.6K ﹤0.01% 1482
2022
Q4 		$25.1K Sell
448
-36
-7% -$1.83K ﹤0.01% 1610
2022
Q3 		$21K Buy
484
+84
+21% +$4.3K ﹤0.01% 1665
2022
Q2 		$22K Buy
400
+348
+669% +$20.9K ﹤0.01% 1625
2022
Q1 		$3K Sell
52
-16
-24% -$1.05K ﹤0.01% 2468
2021
Q4 		$5K Buy
68
+9
+15% +$609 ﹤0.01% 2393
2021
Q3 		$4K Buy
59
+18
+44% +$1.27K ﹤0.01% 2457
2021
Q2 		$3K Hold
41
– – ﹤0.01% 2460
2021
Q1 		$3K Hold
41
– – ﹤0.01% 2372
2020
Q4 		$3K Hold
41
– – ﹤0.01% 2203
2020
Q3 		$2K Sell
41
-7
-15% -$333 ﹤0.01% 2307
2020
Q2 		$2K Buy
48
+12
+33% +$590 ﹤0.01% 2196
2020
Q1 		$1K Buy
+36
New +$1.89K ﹤0.01% 2278
2017
Q1 		– Sell
-180
Closed -$8K – 2025
2016
Q4 		$8K Buy
+180
New +$7.32K ﹤0.01% 1192

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Parallel Advisors's IART Position: Q2 2026 in Review

Parallel Advisors increased its Integra LifeSciences (IART) stake by 148% in Q2 2026, buying an estimated $17.9K and bringing the position to 2,147 shares worth $38.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2302.

Parallel Advisors first reported a position in IART in Q4 2016 and has held it in 27 quarters since. The position peaked at $40.6K in Q1 2023. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Parallel Advisors held 2,147 shares of Integra LifeSciences worth $38.6K as of Q2 2026.
  • Parallel Advisors bought 1,281 Integra LifeSciences shares in Q2 2026, an estimated $17.9K.
  • Integra LifeSciences made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2302 holding.
  • Parallel Advisors first reported a position in Integra LifeSciences in Q4 2016 and has held it in 27 quarters since.
  • Parallel Advisors's Integra LifeSciences position peaked at $40.6K in Q1 2023.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.